FDA Inspection
Baxter Deutschland GmbHBaxter Deutschland GmbH – FDA Inspection, Nov 11, 2022
Record Details
This FDA Inspection record concerns Baxter Deutschland GmbH, with an inspection on November 11, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Baxter Deutschland GmbH
- Inspection Date
- November 11, 2022
- Product Type
- Drugs
View Company Profile
ID · 3a7b7a03-3f8a-45ee-a1e1-ad8c1db5f380
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1193847
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Baxter Deutschland GmbH
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 28, 2025 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 26, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Baxter Deutschland GmbH
- FDA Inspection 1288760 - 2025-05-28
- FDA Inspection 1060487 - 2018-06-14
- FDA Inspection 957912 - 2016-01-22
- FDA Inspection 746997 - 2011-08-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.